The methyltransferases METTL7A and METTL7B confer resistance to thiol-based histone deacetylase inhibitors
Robert W. Robey(National Cancer Institute), Pedro J. Batista(National Institutes of Health)
Cited by 5
Related Papers
The Methyltransferases METTL7A and METTL7B Confer Resistance to Thiol-Based Histone Deacetylase Inhibitors
|Molecular Cancer Therapeutics|2023|15
Rewiring of RNA methylation by the oncometabolite fumarate in renal cell carcinoma
|NAR Cancer|2024|11
Rewiring of RNA methylation by the oncometabolite fumarate in renal cell carcinoma
|bioRxiv (Cold Spring Harbor Laboratory)|2023|0